Bioavailability Assay

BioVenic provides targeted, high-precision aquatic bioavailability assay services for scientific research, supporting the exploration of contaminant migration patterns and ecological hazard mechanisms in aquatic environments. This assay quantifies the uptake, tissue accumulation and distribution of exogenous chemicals, tracking pollutant enrichment throughout embryonic and larval developmental stages of aquatic organisms. Unlike routine water concentration detection, it focuses on biologically effective components, offering essential evidence for assessing real biological exposure risks and ecological enrichment hazards.

Ideal Projects We Support

• Water Pollutant Migration Research: Track the enrichment and accumulation of heavy metals, microplastics and organic toxins in fish embryos, explore pollutant migration patterns in aquatic organisms, and assess food chain enrichment and ecological risks for toxicological studies.
• Novel Aquatic Compound Safety Study: Test bioabsorption and tissue enrichment of innovative aquaculture additives, regulators and remediation materials in aquatic models to supply basic biosafety and application feasibility data.
• Pharmaceutical Residue Ecological Research: Quantify cumulative embryonic absorption of trace drug residues under long-term low-concentration exposure, analyzing links between residue bioavailability and developmental toxicity.
• Aquatic Nutrition Absorption Experiment: Evaluate the bioavailability of feed nutrients and trace elements, clarify their absorption and utilization in fish, and support optimized feed formula development.

Fig 1. Factors that impact bioavailability of micronutrients. ^1,3

Common Challenges We Help Address

• Embryonic yolk matrix and tissue impurities interfere with mass spectrometry detection of trace target pollutants.
• Unstable water pollutant concentration during long exposure leads to inconsistent organism absorption baseline.
• Differences in embryonic developmental stages cause large gaps in contaminant uptake capacity between individuals.
• Improper sample lyophilization and extraction lead to loss of low-concentration target compounds.
• Single tissue testing cannot reflect whole-body average bioavailability levels of aquatic organisms.

Standardized Service Workflow

All testing procedures adopt internal unified experimental specifications to eliminate manual operation errors and guarantee stable quantitative data repeatability.

1. Screening and Embryo Incubation: Select uniformly developed healthy zebrafish embryos and place them in exposure culture plates with gradient concentrations of test substances under stable culture conditions.
2. Whole-cycle Experiment Monitoring: Regularly record water quality parameters and embryonic growth conditions during exposure to exclude abnormal developmental interference factors.
3. Tissue Sample Preparation: Collect complete embryonic samples after exposure terminate biological activity and conduct lyophilization treatment to stabilize target compounds inside tissues.
4. Target Compound Chemical Analysis: Extract test substances from lyophilized samples and use mass spectrometry equipment to quantify the internal concentration of target compounds accurately.
5. Bioconcentration Parameter Calculation: Calculate compound tissue content and bioconcentration factor based on instrument quantitative data to evaluate bioavailability level.
6. Data Analysis & Reporting: Complete inter-group comparison of absorption capacity and output standardized research analysis report with full original test records attached.

Fig 2. Workflow of zebrafish bioavailability assay. (BioVenic Original)

Why Choose BioVenic

• Professional Team: Equipped with aquatic toxicologists and mass spectrometry analytical chemists proficient in biological tissue trace substance extraction and quantitative testing.
• Customized Services: Adjust exposure schemes and tissue extraction methods according to test compound properties and selected aquatic species.
• Innovative Technology: Adopt optimized sample pretreatment protocols to reduce trace pollutant loss and improve quantification sensitivity.

Core Application Scenarios

• Water Environment Pollutant Research

Analyze bioconcentration characteristics of heavy metals microplastics and organic pollutants to judge ecological accumulation risks.

• New Aquatic Compound Safety Research

Evaluate tissue absorption of feed additives and aquatic biological agents to exclude long-term hidden biological hazards.

• Pharmaceutical Residue Toxicology Study

Quantify embryo absorption of waterborne drug residues for aquatic environmental safety exploration.

• Aquatic Nutrition Absorption Research

Test the bioabsorption rate of nutritional active substances to optimize aquaculture feed formula design.

Published Research Background

A peer-reviewed study verified that liposomal nanoencapsulation effectively elevates the bioavailability of poorly water-soluble myricetin in zebrafish embryos. The published data indicated that nanoformulated myricetin achieved higher tissue absorption efficiency than free myricetin, along with enhanced antioxidant enzyme activity and negligible harm to embryonic development.

Building on these published research foundations, BioVenic optimizes standardized detection protocols for compound bioavailability in aquatic organisms. We deliver professional absorption efficiency testing services for diverse nanoformulations and natural active ingredients.

Fig 3. Liposomal nanoencapsulation enhances myricetin bioavailability in zebrafish embryos. ^2,3

Frequently Asked Questions

1. What core data indicators can be obtained from bioavailability assay?
   The core output indicators include tissue compound concentration bioconcentration factor and average embryo absorption rate which can directly judge the pollutant accumulation potential in aquatic organisms.
2. Why lyophilization treatment is required for test embryo samples?
   Lyophilization removes water inside tissues to avoid hydrolysis and loss of trace target compounds during extraction and improve quantification accuracy of mass spectrometry.
3. Can low concentration microplastic samples be quantified in this assay service?
   Yes. our optimized tissue extraction and detection system can capture low-content microplastic particles inside embryonic tissues to complete bioavailability quantitative analysis.

Partner with BioVenic

BioVenic focuses on standardized Aquatic Animal Bioavailability Assay to advance environmental chemical risk assessment and aquatic pharmacology research. Measuring bioavailability quantifies how contaminants or compounds absorb and accumulate in aquatic organisms, laying core evidence for ecological hazard judgment and drug efficacy verification. Our laboratory specialists follow standardized testing workflows to generate consistent, quantitative detection data matching diverse experimental schemes. To discuss your specific project requirements, explore our technical capabilities, or receive a detailed quote for your study, please contact us. Our professional consultants will convert your assay data into solid evidence to drive your research and regulatory evaluation work.

Our products and services are for research use only and cannot be used for any clinical purposes.

Related Services